Global Economic Slowdown and Reduced R&D Spending: Expected downgrades in global growth forecasts, influenced by geopolitical conflicts like in the Middle East, are likely to curtail R&D budgets of pharmaceutical, biotechnology, and academic institutions, which are key customers for Azenta's life sciences solutions. [cite: Context]

Rising Operational Costs impacting Cold-Chain Logistics and Energy-Intensive Operations: Higher oil prices driven by Middle East conflicts increase the operational costs for Azenta, particularly for its energy-intensive cryogenics and cold-chain sample management solutions, as well as global logistics for sample transport and supply chain management. [cite: Context]

Increased Competition and Pricing Pressure in Life Sciences Services: Azenta faces heightened competition within the Multiomics and Sample Management Solutions segments, leading to pricing pressure. This industry-specific challenge can be exacerbated by broader economic cautiousness, prompting customers to seek more cost-effective solutions.